Table 2.
Individual Patient Demographics
| Patient No. | Age | Gender | GCS | Pupils | |
|
|
ISS | Marshall | Rotterdam | Stockholm | Brain injury progression | GOS |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Multi-trauma | HeadAIS | Non-headAIS | |||||||||||
| 1 | 55 | M | 8 | 1 | 0 | 5 | 1 | 26 | VI | 5 | 3.7 | 0 | 4 |
| 2 | 53 | F | 5 | 2 | 0 | 5 | 1 | 25 | VI | 6 | 3.6 | 1 | 3 |
| 4 | 22 | M | 7 | 1 | 1 | 4 | 3 | 29 | VI | 6 | 3.3 | 0 | 3 |
| 5 | 23 | M | 8 | 0 | 0 | 4 | 0 | 16 | III | 4 | 1.5 | 0 | 5 |
| 6 | 20 | M | 8 | 2 | 1 | 3 | 2 | 17 | II | 3 | 1.8 | 1 | 5 |
| 7 | 38 | M | 7 | 0 | 1 | 5 | 3 | 38 | II | 3 | 3.5 | 0 | 3 |
| 8 | 25 | M | 8 | 0 | 0 | 5 | 0 | 25 | IV | 5 | 2 | 0 | 5 |
| 9 | 42 | M | 3 | 1 | 1 | 5 | 3 | 38 | II | 3 | 1.5 | 1 | 3 |
| 10 | 52 | F | 3 | 2 | 1 | 4 | 4 | 29 | III | 4 | 3.5 | 0 | 3 |
| 11 | 59 | M | 7 | 1 | 0 | 5 | 0 | 25 | VI | 4 | 4.9 | 0 | 3 |
| 12 | 62 | M | 3 | 0 | 0 | 5 | 0 | 25 | II | 3 | 2 | 1 | 1 |
| 13 | 49 | M | 3 | 0 | 0 | 4 | 0 | 16 | II | 3 | 1.5 | 0 | 5 |
| 14 | 20 | M | 7 | 0 | 0 | 5 | 0 | 25 | VI | 3 | 2.5 | 0 | 4 |
| 15 | 36 | M | 7 | 0 | 1 | 4 | 3 | 26 | III | 4 | 2.8 | 0 | 4 |
| 16 | 60 | F | 4 | 0 | 0 | 5 | 1 | 25 | VI | 4 | 2.5 | 0 | 4 |
| 17 | 48 | M | 4 | 2 | 0 | 5 | 0 | 25 | VI | 5 | 3.8 | 1 | 1 |
Demographic data of the patient cohort, depicted as each subject's raw data value. One patient (no. 3) was excluded from all analyses because of a lack of albuminCSF samples.
Clinical data upon admission: age (years); gender: M (male), F (female); GCS (Glasgow Coma Scale Score) 3-15; pupils (pupil responsiveness), 0 = bilateral responsive; 1 = unilateral unresponsive; 2 = bilateral unresponsive; multi-trauma, 1 = yes, 0 = no.
Injury scores upon admission: Head and non-head Abbreviated Injury Scale (AIS), (1) minor, (2) moderate, (3) serious, (4) severe, (5) critical, (6) maximum. Injury Severity Score (ISS) (1–75).
Classification upon admission computed tomography (CT): Marshall, (I) no visible pathology,(II) diffuse injury, (III) “swelling,” (IV) shift, V–VI (“mass lesion”). Rotterdam, classes 1–6. Stockholm, tally based. Brain injury progression: 1 = yes, 0 = no.
Outcome data at 6 months follow-up: Glasgow Outcome Scale Score (GOS): (GOS1) dead, (GOS2) persistent vegetative state, (GOS3) severe disability, (GOS4) moderate disability, (GOS5) good recovery.